Consolidated Statement of Cash Flow II
Consolidated statement of cash flows for the years ended 31 December
| |
| | | |
|
| |
| | | | |
|
| Balance carried forward from previous page | |
| 6 533 | | 334 | |
|
| |
| | | | |
| Cash flows from financing activities | |
| | | | |
|
| Issuance of subordinated perpetual notes | |
| – | | 1 140 | |
|
| Issuance of other debt instruments | |
| 413 | | 208 | |
|
| Redemption of debt instruments | |
| –705 | | –266 | |
|
| Reduction in par value | |
| –547 | | –234 | |
|
| Premiums paid/received for options on own shares | |
| – | | –6 | |
|
| Purchases of treasury shares | |
| –711 | | –1 313 | |
|
| Sales of treasury shares | |
| 144 | | 754 | |
|
| Capital contributions from minority interest | |
| 10 | | 24 | |
|
| Borrowing costs paid | |
| –172 | | –136 | |
|
| Dividends paid to minority interest | |
| –4 | | –12 | |
|
| Total net cash flows from financing activities | |
| –1 572 | | 159 | |
|
| |
| | | | |
|
| Total change in cash and cash equivalents | |
| 4 961 | | 493 | |
|
| |
| | | | |
|
| Cash and cash equivalents as at 1 January | |
| 4 555 | | 7 621 | |
|
| Classification as assets held for sale | |
| – | | –3 591 | |
|
| Effect of exchange rate differences | |
| –108 | | 32 | |
|
| Total change in cash and cash equivalents | |
| 4 961 | | 493 | |
|
| Cash and cash equivalents as at 31 December | |
| 9 408 | | 4 555 | |
|
| |
| | | | |
| Components of cash and cash equivalents | |
| | | | |
|
| Cash on hand and demand deposits | |
| 3 887 | | 1 725 | |
|
| Cash equivalents | |
| 4 234 | | 1 012 | |
|
| Cash and cash equivalents for the account and risk of the Swiss Life Group's customers | |
| 1 287 | | 1 818 | |
|
| Total cash and cash equivalents as at 31 December | |
| 9 408 | | 4 555 | |
|
